Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist

Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4761-8. doi: 10.1167/iovs.08-2732. Epub 2009 May 20.

Abstract

Purpose: To address the roles of the endogenously produced IL-1ra in the course of corneal neovascularization (CNV).

Methods: CNV was induced by alkali injury and compared in wild-type (WT), IL-1 receptor antagonist (ra) knockout (KO) mice and anti-IL-1ra antibody-treated WT mice 2 weeks after injury. Angiogenic factor expression and leukocyte accumulation in the early phase after injury were quantified by RT-PCR and immunohistochemical analysis, respectively.

Results: The mRNA expression of IL-1ra, IL-1 alpha, and IL-1beta was augmented, together with infiltration of F4/80(+) macrophages and Gr-1(+) neutrophils, in corneas after alkali injury. Intracorneally infiltrating macrophages, but not neutrophils, expressed IL-1ra. Compared with WT mice, either IL-1ra KO mice or anti-IL-1ra antibody-treated WT mice exhibited enhanced CNV 2 weeks after injury, as evidenced by enlarged CD31(+) areas. Concomitantly, the infiltration of F4/80(+) macrophages was more significantly enhanced in IL-1ra KO mice than in WT mice. Intraocular mRNA expression enhancement of vascular endothelial growth factor (VEGF) and inducible nitric oxide synthase (iNOS) was greater in IL-1ra KO mice than in WT mice after injury. Moreover, IL-1 alpha and IL-1 beta enhanced VEGF and iNOS expression by murine peritoneal macrophages.

Conclusions: IL-1ra KO exhibited enhanced alkali-induced CNV through enhanced intracorneal macrophage infiltration and increased expression of VEGF and iNOS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Differentiation
  • Burns, Chemical / etiology
  • Cornea / drug effects
  • Corneal Neovascularization / etiology*
  • Corneal Neovascularization / metabolism*
  • Disease Models, Animal*
  • Eye Burns / chemically induced
  • Fluorescent Antibody Technique, Indirect
  • Interleukin 1 Receptor Antagonist Protein / physiology*
  • Interleukin-1alpha / metabolism
  • Interleukin-1beta / metabolism
  • Macrophages / physiology
  • Macrophages, Peritoneal / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Neutrophils / physiology
  • Nitric Oxide Synthase Type II / metabolism*
  • RNA, Messenger / metabolism
  • Reverse Transcriptase Polymerase Chain Reaction
  • Sodium Hydroxide / toxicity
  • Vascular Endothelial Growth Factor A / metabolism*

Substances

  • Antigens, Differentiation
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1alpha
  • Interleukin-1beta
  • RNA, Messenger
  • Vascular Endothelial Growth Factor A
  • monocyte-macrophage differentiation antigen
  • vascular endothelial growth factor A, mouse
  • Sodium Hydroxide
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse